Filing Flows › ASP Isotopes (ASPI) › Q1 2026 › vs Q1 2025
ASP Isotopes (ASPI) Q1 2026 vs Q1 2025 (year over year)
ASP Isotopes's revenue rose $3.1M (+279%) from $1.1M in Q1 2025 to $4.2M in Q1 2026. The biggest changes: Product +$2.9M (+261%); Collaboration Revenue +$200K (—).
ASP Isotopes, Q1 2026: revenue $4.2M (+279% year over year), operating margin -595.4%, net loss $7.1M, operating cash flow −$17.8M. The chart draws each line against Q1 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q1 2025 | Change | % |
|---|---|---|---|---|
| Product | $4.0M | $1.1M | $2.9M | +261% |
| Collaboration Revenue | $200K | $0 | $200K | — |
| Revenue | $4.2M | $1.1M | $3.1M | +279% |
| Other income, net | $17.7M | −$580K | $18.3M | — |
| Income tax benefit | $31K | $71K | −$40K | -56% |
| Net loss | $7.1M | $8.5M | −$1.3M | -16% |
| Costs & expenses | $29.1M | $9.6M | $19.4M | +202% |
| Operating costs | $29.1M | $9.1M | $20.0M | +221% |
| Cost of revenue | $2.5M | $775K | $1.7M | +224% |
| Research & development | $5.3M | $1.5M | $3.7M | +244% |
| General & admin | $21.3M | $6.7M | $14.5M | +215% |
| Operating cash sources | $25.2M | $5.2M | $20.0M | +384% |
| Depreciation & amortization | $3.1M | $149K | $2.9M | 21× |
| Share-based compensation | $4.4M | $1.9M | $2.5M | +133% |
| Cash used in operations | $17.8M | $3.2M | $14.6M | +460% |
| Net loss absorbed | $7.1M | $8.5M | −$1.3M | -16% |
| Working capital & other | $18.1M | −$3.3M | $21.4M | — |
Questions
How much did ASP Isotopes's revenue grow year over year in Q1 2026?
ASP Isotopes's revenue rose $3.1M (+279%) from $1.1M in Q1 2025 to $4.2M in Q1 2026.
What drove ASP Isotopes's revenue change in Q1 2026?
Product +$2.9M (+261%); Collaboration Revenue +$200K (—).